Category: Oncology
FDA approves Mosunetuzumab for relapsed or refractory Follicular Lymphoma
The FDA in December 2022 has approved Mosunetuzumab in relapsed or refractory Follicular Lymphoma. The drug is approved for patients who had received at least…
Xermelo (telotristat ethyl) for carcinoid syndrome diarrhea
Xermelo (telotristat ethyl) tablets can be used in combination with somatostatin analog (SSA) therapy for the treatment of carcinoid syndrome diarrhea. It has been shown…
Immunotherapy before surgery (Neoadjuvant pembrolizumab) in Melanoma patients
This was studied in a phase 2 study, in patients with stage III or IV resectable melanoma patients. The results were presented at ESMO 2022…
An important class of cancer drugs – Antibody Drug Conjugates (ADCs)
The antibody drug conjugates are a new class of drugs in the filed of Cancer Medicine. They are also called as ADCs. It is an…
New treatment Futibatinib (Lytgobi) approved for intrahepatic cholangiocarcinoma
Cholangiocarcinomas are bile duct cancers. The bile ducts are thin ducts or tubes that go from liver and gall bladder to the small intestine. The…
Renal Cell Carcinoma – new triplet treatment beat doublet in Progression Free Survival (PFS)
Kidney Cancer or Renal Cell Carcinoma treatment has been evolving. The new study COSMIC-313 presented the data of three drug combination Cabozantinib, Nivolumab and ipilimumab….
What can you do to find Lung Cancer early?
Are there any screening tests for lung cancer? Yes, low dose CT chest (LDCT) scan can be performed to screen lung cancer. It may help…
Immunotherapy Durvalumab with chemotherapy improved survival in Biliary Tract Cancer
Durvalumab immunotherapy improved overall survival in biliary tract cancer patients when added to standard chemotherapy. September 2022, US FDA approved this combination treatment for biliary…
Multiple Myeloma – new treatment with biclonal antibodies (Teclistamab)
Teclistamab is a new antibody drug for multiple myeloma patients. It is classified as a bispecific antibodies. These antibodies are capable of binding to T-cells…
Immunotherapy and chemotherapy in Triple Negative Breast Cancer (TNBC) – New treatment before surgery
The addition of immunotherapy has shown improvement in distant recurrence. The results were discussed in Keynote-522 study. The study used pembrolizumab as the drug for…